Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “intranasal”

13 pharma patents match "intranasal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 13
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 13 pharmaceutical patents matching "intranasal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

13 results for “intranasal” · 30,257 patents in full index Clear search

  1. US 11851481

    Treatment of central nervous system disorders by intranasal administration of immunoglobulin g

    Takeda Pharmaceutical Company Limited · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted

  2. US 11224646

    Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  3. US 10682310

    Therapeutic compounds and formulations for intranasal delivery

    Regents of the University of Minnesota · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  4. US 10543283

    Intranasal administration of guanidinylated aminoglycosides

    The Regents of the University of California · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  5. US 9757468

    Intranasal administration of guanidinylated aminoglycosides

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  6. US 9592207

    Intranasal administration of ketamine to treat depression

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  7. US 9585935

    Intranasal oxytocin treatment to improve schizophrenia

    The Regents of the University of California · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted

  8. US 9249424

    Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases

    Regents of the University of Minnesota · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  9. US 8609088

    Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases

    Regents of the University of Minnesota · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  10. US 8518390

    Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  11. US 7641906

    Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  12. US 7112332

    Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides

    The United States of America as represented by the Secretary of the Army · Granted Sep 26, 2006 · Expires Sep 21, 2026

    granted

  13. US 6090368

    Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Jul 18, 2000 · Expires Jul 13, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.